287 results on '"Apparailly F"'
Search Results
102. In vitroand in vivodifferentiation of mesenchymal stem cells into chondrocytes
- Author
-
Noël, D, Apparailly, F, Millet, V, Sany, J, and Jorgensen, C
- Published
- 2001
- Full Text
- View/download PDF
103. Abnormal Immune Profile in Individuals with Kabuki Syndrome.
- Author
-
Comel M, Saad N, Sil D, Apparailly F, Willems M, Djouad F, Andrau JC, Lozano C, and Genevieve D
- Subjects
- Humans, Female, Male, Child, Adolescent, Child, Preschool, Adult, Young Adult, Infant, Lymphopenia immunology, Lymphopenia genetics, Phenotype, Hematologic Diseases genetics, Hematologic Diseases immunology, Mutation, Lymphocyte Subsets immunology, Lymphocyte Subsets metabolism, Immunophenotyping, Vestibular Diseases genetics, Vestibular Diseases immunology, Face abnormalities, Abnormalities, Multiple genetics, Abnormalities, Multiple immunology, DNA-Binding Proteins genetics, Histone Demethylases genetics, Neoplasm Proteins genetics, Neoplasm Proteins immunology
- Abstract
Objective: To analyze the lymphocyte subsets in individuals with Kabuki syndrome for better characterizing the immunological phenotype of this rare congenital disorder., Methods: We characterized the immunological profile including B-, T- and natural killer-cell subsets in a series (N = 18) of individuals with Kabuki syndrome., Results: All 18 individuals underwent genetic analysis: 15 had a variant in KMT2D and 3 a variant in KDM6A. Eleven of the 18 individuals (61%) had recurrent infections and 9 (50%) respiratory infections. Three (17%) had autoimmune diseases. On immunological analysis, 6 (33%) had CD4 T-cell lymphopenia, which was preferentially associated with the KMT2D truncating variant (5/9 individuals). Eight of 18 individuals (44%) had a humoral deficiency and eight (44%) had B lymphopenia. We found abnormal distributions of T-cell subsets, especially a frequent decrease in recent thymic emigrant CD4 + naive T-cell count in 13/16 individuals (81%)., Conclusion: The immunological features of Kabuki syndrome showed variable immune disorders with CD4 + T-cell deficiency in one third of cases, which had not been previously reported. In particular, we found a reduction in recent thymic emigrant naïve CD4 + T-cell count in 13 of 16 individuals, representing a novel finding that had not previously been reported., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
104. MicroRNAs in inflammasomopathies.
- Author
-
Saad N, Duroux-Richard I, Touitou I, Jeziorski E, and Apparailly F
- Subjects
- Humans, Immunity, Innate, Inflammasomes metabolism, Cytokines, MicroRNAs genetics, Hereditary Autoinflammatory Diseases genetics
- Abstract
microRNAs (miRNAs) are small non-coding RNA sequences that negatively regulate the expression of protein-encoding genes at the post-transcriptional level. They play a role in the regulation of inflammatory responses by controlling the proliferation and activation of immune cells and their expression is disrupted in several immune-mediated inflammatory disorders. Among these, autoinflammatory diseases (AID) are a group of rare hereditary disorders caused by abnormal activation of the innate immune system and characterized by recurrent fevers. Major groups of AID are inflammasomopathies, which are associated with hereditary defects in the activation of inflammasomes, cytosolic multiprotein signaling complexes regulating IL-1 family cytokine maturation and pyroptosis. The study of the role of miRNAs in AID is only recently emerging and remains scarce in inflammasomopathies. In this review, we describe the AID and inflammasomopathies, and the current knowledge on the role of miRNAs in disease processes., Competing Interests: Declaration of Competing Interest The authors have declared no conflicts of interest., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF
105. Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis.
- Author
-
Madel MB, Halper J, Ibáñez L, Claire L, Rouleau M, Boutin A, Mahler A, Pontier-Bres R, Ciucci T, Topi M, Hue C, Amiaud J, Iborra S, Sancho D, Heymann D, Garchon HJ, Czerucka D, Apparailly F, Duroux-Richard I, Wakkach A, and Blin-Wakkach C
- Subjects
- Animals, Mice, Osteogenesis, Toll-Like Receptor 2, Saccharomyces genetics, Saccharomyces metabolism, Osteoporosis therapy, Probiotics
- Abstract
Bone destruction is a hallmark of chronic inflammation, and bone-resorbing osteoclasts arising under such a condition differ from steady-state ones. However, osteoclast diversity remains poorly explored. Here, we combined transcriptomic profiling, differentiation assays and in vivo analysis in mouse to decipher specific traits for inflammatory and steady-state osteoclasts. We identified and validated the pattern-recognition receptors (PRR) Tlr2, Dectin-1, and Mincle, all involved in yeast recognition as major regulators of inflammatory osteoclasts. We showed that administration of the yeast probiotic Saccharomyces boulardii CNCM I-745 ( Sb ) in vivo reduced bone loss in ovariectomized but not sham mice by reducing inflammatory osteoclastogenesis. This beneficial impact of Sb is mediated by the regulation of the inflammatory environment required for the generation of inflammatory osteoclasts. We also showed that Sb derivatives as well as agonists of Tlr2, Dectin-1, and Mincle specifically inhibited directly the differentiation of inflammatory but not steady-state osteoclasts in vitro. These findings demonstrate a preferential use of the PRR-associated costimulatory differentiation pathway by inflammatory osteoclasts, thus enabling their specific inhibition, which opens new therapeutic perspectives for inflammatory bone loss., Competing Interests: MM, JH, LI, LC, MR, AB, AM, RP, TC, MT, CH, JA, SI, DS, DH, HG, FA, ID, AW No competing interests declared, DC, CB received a research grant from Biocodex. Biocodex had no role in the design of the study, in the analysis and interpretation of the data and in the preparation of the manuscript
- Published
- 2023
- Full Text
- View/download PDF
106. miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study.
- Author
-
Duroux-Richard I, Gagez AL, Alaterre E, Letestu R, Khalifa O, Jorgensen C, Leprêtre S, Tchernonog E, Moreaux J, Cartron G, and Apparailly F
- Subjects
- Humans, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Neoplasm, Residual genetics, Rituximab, Treatment Outcome, Tumor Microenvironment, Clinical Studies as Topic, Leukemia, Lymphocytic, Chronic, B-Cell diagnosis, Leukemia, Lymphocytic, Chronic, B-Cell drug therapy, Leukemia, Lymphocytic, Chronic, B-Cell genetics, MicroRNAs genetics, MicroRNAs therapeutic use
- Abstract
During many years, chemo-immunotherapy fludarabine-cyclophosphamide-rituximab (FCR) was the gold standard for first line treatment of medically fit patients with symptomatic B-chronic lymphocytic leukemia (CLL). Over the last decade, targeted biotherapies have revolutionized the treatment of B-CLL patients and almost entirely supplanted FCR. However, no biomarker still exists to predict the complete remission (CR) with undetectable minimal residual disease (uMRD) in bone marrow (BM), which remains the best predictive factor for survival. MicroRNAs represent a class of molecular biomarkers which expression is altered in B-CLL. Our study aimed at identifying before treatment blood miRNAs that predict treatment outcome in previously untreated B-CLL patients (NCT01370772, https://clinicaltrials.gov/ct2/show/NCT01370772). Using hierarchical clustering of miRNA expression profiles discriminating 8 patients who achieved CR with BM uMRD from 8 patients who did not achieve CR and displayed detectable BM MRD, we identified 25 miRNAs differentially expressed before treatment. The expression of 11 miRNAs was further validated on a larger cohort (n=123). Based on the dosage of 5 miRNAs at diagnosis, a decision tree was constructed to predict treatment outcome. We identified 6 groups of patients with a distinct probability of being CR with BM uMRD to FCR treatment, ranging from 72% (miR-125b, miR-15b and miR-181c high) to 4% (miR-125b and miR-193b low). None of the patients displaying high expression levels of miR-125b, miR-15b and miR-181c relapsed during study follow-up. In contrast, patients with low miR-15b and high miR-412, or with low miR-125b and miR-193b, demonstrated significant low PFS. RNA sequencing of blood at diagnosis identified that patients relapsing after treatment are characterized by significant enrichment of gene signatures related to cell cycle, MYC target genes, metabolism and translation regulation. Conversely, patients achieving CR with BM uMRD displayed significant enrichment in genes related to communication between CLL cells and the microenvironment, immune system activation and upregulation of polycomb PRC2 complex target genes. Our results suggest that blood miRNAs are potent predictive biomarkers for FCR treatment efficacy and might be implicated in the FCR efficacy in B-CLL patients, providing new insight into unmet need for the treatment of B-CLL patients and identifying pathways predictive of patients' remission., Clinical Trial Registration: ClinicalTrials.gov, identifier NCT01370772., Competing Interests: Author GC received consultancy by Roche and BMS and honoraria from Roche, BMS, Jansen, Novartis and Gilead. Author ET received consultancy and honoraria from Janssen and Abbvie. Author SL received honoraria from Gilead, Janssen, Beigene, Abbvie, Astra Zeenca. Author OK was employed by Erasmus Mundus (2013-2016). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest., (Copyright © 2022 Duroux-Richard, Gagez, Alaterre, Letestu, Khalifa, Jorgensen, Leprêtre, Tchernonog, Moreaux, Cartron and Apparailly.)
- Published
- 2022
- Full Text
- View/download PDF
107. Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force.
- Author
-
Ovseiko PV, Gossec L, Andreoli L, Kiltz U, van Mens L, Hassan N, van der Leeden M, Siddle HJ, Alunno A, McInnes IB, Damjanov NS, Apparailly F, Ospelt C, van der Horst-Bruinsma IE, Nikiphorou E, Druce KL, Szekanecz Z, Sepriano A, Avcin T, Bertsias G, Schett G, Keenan AM, Pololi LH, and Coates LC
- Subjects
- Cross-Sectional Studies, Europe epidemiology, Female, Gender Equity, Humans, Male, Rheumatologists, Rheumatology
- Abstract
Objectives: Evidence on the current status of gender equity in academic rheumatology in Europe and potential for its improvement is limited. The EULAR convened a task force to obtain empirical evidence on the potential unmet need for support of female rheumatologists, health professionals and non-clinical scientists in academic rheumatology., Methods: This cross-sectional study comprised three web-based surveys conducted in 2020 among: (1) EULAR scientific member society leaders, (2) EULAR and Emerging EULAR Network (EMEUNET) members and (3) EULAR Council members. Statistics were descriptive with significance testing for male/female responses assessed by χ
2 test and t-test., Results: Data from EULAR scientific member societies in 13 countries indicated that there were disproportionately fewer women in academic rheumatology than in clinical rheumatology, and they tended to be under-represented in senior academic roles. From 324 responses of EULAR and EMEUNET members (24 countries), we detected no gender differences in leadership aspirations, self-efficacy in career advancement and work-life integration as well as the share of time spent on research, but there were gender differences in working hours and the levels of perceived gender discrimination and sexual harassment. There were gender differences in the ranking of 7 of 26 factors impacting career advancement and of 8 of 24 potential interventions to aid career advancement., Conclusions: There are gender differences in career advancement in academic rheumatology. The study informs a EULAR task force developing a framework of potential interventions to accelerate gender-equitable career advancement in academic rheumatology., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)- Published
- 2022
- Full Text
- View/download PDF
108. Mitochondrial MicroRNAs Contribute to Macrophage Immune Functions Including Differentiation, Polarization, and Activation.
- Author
-
Duroux-Richard I, Apparailly F, and Khoury M
- Abstract
A subset of microRNA (miRNA) has been shown to play an important role in mitochondrial (mt) functions and are named MitomiR. They are present within or associated with mitochondria. Most of the mitochondrial miRNAs originate from the nucleus, while a very limited number is encoded by mtDNA. Moreover, the miRNA machinery including the Dicer and Argonaute has also been detected within mitochondria. Recent, literature has established a close relationship between miRNAs and inflammation. Indeed, specific miRNA signatures are associated with macrophage differentiation, polarization and functions. Nevertheless, the regulation of macrophage inflammatory pathways governed specifically by MitomiR and their implication in immune-mediated inflammatory disorders remain poorly studied. Here, we propose a hypothesis in which MitomiR play a key role in triggering macrophage differentiation and modulating their downstream activation and immune functions. We sustain this proposition by bioinformatic data obtained from either the human monocytic THP1 cell line or the purified mitochondrial fraction of PMA-induced human macrophages. Interestingly, 22% of the 754 assayed miRNAs were detected in the mitochondrial fraction and are either exclusively or highly enriched cellular miRNA. Furthermore, the in silico analysis performed in this study, identified a specific MitomiR signature associated with macrophage differentiation that was correlated with gene targets within the mitochondria genome or with mitochondrial pathways. Overall, our hypothesis and data suggest a previously unrecognized link between MitomiR and macrophage function and fate. We also suggest that the MitomiR-dependent control could be further enhanced through the transfer of mitochondria from donor to target cells, as a new strategy for MitomiR delivery., Competing Interests: MK was the chief scientific officer of Cells for Cells and Regenero, the Chilean Consortium for Regenerative Medicine. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Duroux-Richard, Apparailly and Khoury.)
- Published
- 2021
- Full Text
- View/download PDF
109. Integrative Analysis of Human Macrophage Inflammatory Response Related to Mycobacterium tuberculosis Virulence.
- Author
-
Bade P, Simonetti F, Sans S, Laboudie P, Kissane K, Chappat N, Lagrange S, Apparailly F, Roubert C, and Duroux-Richard I
- Subjects
- Adaptive Immunity, Apoptosis, Cytokines genetics, Gene Expression Regulation, Host-Pathogen Interactions, Humans, Lung immunology, Lung metabolism, Macrophages immunology, Macrophages metabolism, MicroRNAs genetics, MicroRNAs metabolism, Mycobacterium Infections, Nontuberculous immunology, Mycobacterium Infections, Nontuberculous metabolism, Mycobacterium Infections, Nontuberculous microbiology, Mycobacterium marinum immunology, Mycobacterium marinum pathogenicity, Mycobacterium tuberculosis immunology, Signal Transduction, THP-1 Cells, Transcriptome, Tuberculosis genetics, Tuberculosis immunology, Tuberculosis metabolism, Virulence, Cytokines metabolism, Inflammation Mediators metabolism, Lung microbiology, Macrophages microbiology, Mycobacterium tuberculosis pathogenicity, Tuberculosis microbiology
- Abstract
Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis, kills 1.5 to 1.7 million people every year. Macrophages are Mtb's main host cells and their inflammatory response is an essential component of the host defense against Mtb. However, Mtb is able to circumvent the macrophages' defenses by triggering an inappropriate inflammatory response. The ability of Mtb to hinder phagolysosome maturation and acidification, and to escape the phagosome into the cytosol, is closely linked to its virulence. The modulation of the host inflammatory response relies on Mtb virulence factors, but remains poorly studied. Understanding macrophage interactions with Mtb is crucial to develop strategies to control tuberculosis. The present study aims to determine the inflammatory response transcriptome and miRNome of human macrophages infected with the virulent H37Rv Mtb strain, to identify macrophage genetic networks specifically modulated by Mtb virulence. Using human macrophages infected with two different live strains of mycobacteria (live or heat-inactivated Mtb H37Rv and M. marinum ), we quantified and analyzed 184 inflammatory mRNAs and 765 micro(mi)RNAs. Transcripts and miRNAs differently modulated by H37Rv in comparison with the two other conditions were analyzed using in silico approaches. We identified 30 host inflammatory response genes and 37 miRNAs specific for H37Rv virulence, and highlight evidence suggesting that Mtb intracellular-linked virulence depends on the inhibition of IL-1β-dependent pro-inflammatory response, the repression of apoptosis and the delay of the recruitment and activation of adaptive immune cells. Our findings provide new potential targets for the development of macrophage-based therapeutic strategies against TB., Competing Interests: Authors PB, FS, SS, PL, KK, NC, SL and CR were employed by the company Evotec ID. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declare that this study received funding from Evotec ID. The funder had the following involvement with the study: sharing H37rv related protocols, managing training and BSL3 space relative to this study, interpreting data and participating to project meetings., (Copyright © 2021 Bade, Simonetti, Sans, Laboudie, Kissane, Chappat, Lagrange, Apparailly, Roubert and Duroux-Richard.)
- Published
- 2021
- Full Text
- View/download PDF
110. 'SMASH' recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models.
- Author
-
Hayer S, Vervoordeldonk MJ, Denis MC, Armaka M, Hoffmann M, Bäcklund J, Nandakumar KS, Niederreiter B, Geka C, Fischer A, Woodworth N, Blüml S, Kollias G, Holmdahl R, Apparailly F, and Koenders MI
- Subjects
- Animals, Disease Models, Animal, Humans, Mice, Mice, Transgenic, Rats, Reproducibility of Results, Arthritis, Experimental pathology, Arthritis, Rheumatoid pathology
- Abstract
Animal models for inflammatory arthritides such as rheumatoid arthritis (RA) and psoriatic arthritis are widely accepted and frequently used to identify pathological mechanisms and validate novel therapeutic strategies. Unfortunately, many publications reporting on these animal studies lack detailed description and appropriate assessment of the distinct histopathological features of arthritis: joint inflammation, cartilage damage and bone erosion. Therefore, the European consortium BeTheCure, consisting of 38 academic and industrial partners from 15 countries, set as goal to standardise the histological evaluation of joint sections from animal models of inflammatory arthritis. The consensual approach of a task force including 16 academic and industrial scientists as well as laboratory technicians has resulted in the development of the Standardised Microscopic Arthritis Scoring of Histological sections ('SMASH') recommendations for a standardised processing and microscopic scoring of the characteristic histopathological features of arthritis, exemplified by four different rodent models for arthritis: murine collagen-induced arthritis, collagen-antibody-induced arthritis, human tumour necrosis factor transgenic Tg197 mice and rat pristane-induced arthritis, applicable to any other inflammatory arthritis model. Through standardisation, the SMASH recommendations are designed to improve and maximise the information derived from in vivo arthritis experiments and to promote reproducibility and transparent reporting on such studies. In this manuscript, we will discuss and provide recommendations for analysis of histological joint sections: identification of the regions of interest, sample preparation, staining procedures and quantitative scoring methods. In conclusion, awareness of the different features of the arthritis pathology in animal models of inflammatory arthritis is of utmost importance for reliable research outcome, and the standardised histological processing and scoring methods in these SMASH recommendations will help increase uniformity and reproducibility in preclinical research on inflammatory arthritis., Competing Interests: Competing interests: MCD, CG and GK report personal fees from Biomedcode, outside the submitted work; and Biomedcode is a service provider of in vivo efficacy studies within the area of inflammatory diseases. NW is employed by Redoxis AB; and Redoxis AB is a service provider selling in vivo studies within the area of autoimmunity and inflammation., (© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
111. Synovial macrophages: from ordinary eaters to extraordinary multitaskers.
- Author
-
Hannemann N, Apparailly F, and Courties G
- Subjects
- Humans, Macrophages
- Abstract
Like other tissues, joints contain resident macrophages, and their diversity is only beginning to be characterized. Based on the highlights of recent studies, we discuss where current challenges lie and propose new avenues for future research in the osteoarticular field., Competing Interests: Declaration of interests The authors declare no conflicts of interest., (Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
112. Novel insights into macrophage diversity in rheumatoid arthritis synovium.
- Author
-
Boutet MA, Courties G, Nerviani A, Le Goff B, Apparailly F, Pitzalis C, and Blanchard F
- Subjects
- Humans, Macrophages, Synovial Membrane, T-Lymphocytes, Arthritis, Rheumatoid, Synovitis
- Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease affecting joints and causing progressive damage and disability. Macrophages are of critical importance in the initiation and perpetuation of synovitis in RA, they can function as antigen presenting cells leading to T-cell dependent B-cell activation, assume a variety of inflammatory cell states with the production of destructive cytokines, but also contribute to tissue homeostasis/repair. The recent development of high-throughput technologies, including bulk and single cells RNA-sequencing, has broadened our understanding of synovial cell diversity, and opened novel perspectives to the discovery of new potential therapeutic targets in RA. In this review, we will focus on the relationship between the synovial macrophage infiltration and clinical disease severity and response to treatment. We will then provide a state-of-the-art picture of the biological roles of synovial macrophages and distinct macrophage subsets described in RA. Finally, we will review the effects of approved conventional and biologic drugs on the synovial macrophage component and highlight the therapeutic potential of future strategies to re-program macrophage phenotypes in RA., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
113. TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS.
- Author
-
Rittore C, Méchin D, Sanchez E, Marinèche L, Ea V, Soler S, Vereecke M, Mallavialle A, Richard E, Duroux-Richard I, Apparailly F, Touitou I, and Grandemange S
- Subjects
- Cell Line, Cell Line, Tumor, Exons genetics, HEK293 Cells, HeLa Cells, Humans, NF-kappa B genetics, Hereditary Autoinflammatory Diseases genetics, Hereditary Autoinflammatory Diseases pathology, Mutation genetics, Receptors, Tumor Necrosis Factor, Type I genetics, Signal Transduction genetics, Tumor Necrosis Factor-alpha genetics
- Abstract
Binding of tumour necrosis factor α (TNFα) to its receptor (TNFR1) is critical for both survival and death cellular pathways. TNFα/TNFR1 signalling is complex and tightly regulated at different levels to control cell fate decisions. Previously, we identified TNFR1-d2, an exon 2-spliced transcript of TNFRSF1A gene encoding TNFR1, whose splicing may be modulated by polymorphisms associated with inflammatory disorders. Here, we investigated the impact of TNFRSF1A variants involved in TNFR-associated periodic syndrome (TRAPS) on TNFR1-d2 protein expression and activity. We found that TNFR1-d2 could be translated by using an internal translation initiation codon and a de novo internal ribosome entry site (IRES), which resulted in a putative TNFR1 isoform lacking its N-terminal region. The kinetic of assembly of TNFR1-d2 clusters at the cell surface was reduced as compared with full-length TNFR1. Although co-localized with the full-length TNFR1, TNFR1-d2 neither activated nuclear factor (NF)-κB signalling, nor interfered with TNFR1-induced NF-κB activation. Translation of TNFR1-d2 carrying the severe p.(Thr79Met) pathogenic variant (also known as T50M) was initiated at the mutated codon, resulting in an elongated extracellular domain, increased speed to form preassembled clusters in absence of TNFα, and constitutive NF-κB activation. Overall, TNFR1-d2 might reflect the complexity of the TNFR1 signalling pathways and could be involved in TRAPS pathophysiology of patients carrying the p.(Thr79Met) disease-causing variant.
- Published
- 2021
- Full Text
- View/download PDF
114. New insights into macrophage heterogeneity in rheumatoid arthritis.
- Author
-
Hannemann N, Apparailly F, and Courties G
- Subjects
- Animals, Humans, Inflammation, Macrophages, Monocytes, Arthritis, Rheumatoid genetics, Synovial Membrane
- Abstract
Rheumatoid arthritis (RA) is a prototypic autoimmune disease that primarily affects joints. Clinical studies and animal models evidenced that mononuclear phagocytes including monocytes and macrophages are crucial to RA pathogenesis, contributing to inflammation and destruction of cartilage and bone. The last decade of research has tremendously changed our view on the origin of tissue-resident macrophages. In light of the recent publications that reveal important phenotypic and functional heterogeneity among macrophages, it is of paramount importance to identify the synovial macrophage subsets that might amplify the inflammatory response or promote the restoration of tissue homeostasis. In this review, we highlight latest studies applying single-cell RNA sequencing that provide deeper insights in macrophage subsets and their putative functions within both human and mouse synovial joint tissue., (Copyright © 2020 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
115. Dysregulation of microRNA expression in the skin during cutaneous adverse drug reactions.
- Author
-
Pedruzzi E, Chasset F, Duroux-Richard I, Bocarra D, Apparailly F, Nourikyan J, Lumy M, de Bernard S, Bonduelle O, Buffat L, Combadière B, and Soria A
- Subjects
- Humans, Skin, Drug Hypersensitivity Syndrome, Exanthema, MicroRNAs genetics
- Published
- 2020
- Full Text
- View/download PDF
116. Clinical and Molecular Spectrum of Nonsyndromic Early-Onset Osteoarthritis.
- Author
-
Ruault V, Yauy K, Fabre A, Fradin M, Van-Gils J, Angelini C, Baujat G, Blanchet P, Cuinat S, Isidor B, Jorgensen C, Lacombe D, Moutton S, Odent S, Sanchez E, Sigaudy S, Touitou I, Willems M, Apparailly F, Geneviève D, and Barat-Houari M
- Subjects
- Adolescent, Age of Onset, Aggrecans genetics, Body Mass Index, Disease Progression, Female, Genetic Predisposition to Disease, Humans, Male, Osteoarthritis genetics, Sulfate Transporters genetics, Young Adult, Collagen Type II genetics, Osteoarthritis diagnosis
- Abstract
Objective: Osteoarthritis (OA) is the most common joint disease worldwide. The etiology of OA is varied, ranging from multifactorial to environmental to monogenic. In a condition called early-onset OA, OA occurs at an earlier age than is typical in the general population. To our knowledge, there have been no large-scale genetic studies of individuals with early-onset OA. The present study was undertaken to investigate causes of monogenic OA in individuals with nonsyndromic early-onset OA., Methods: The study probands were 45 patients with nonsyndromic early-onset OA who were referred to our skeletal disease center by skeletal dysplasia experts between 2013 and 2019. Criteria for early-onset OA included radiographic evidence, body mass index ≤30 kg/m
2 , age at onset ≤50 years, and involvement of ≥1 joint site. Molecular analysis was performed with a next-generation sequencing panel., Results: We identified a genetic variant in 13 probands (29%); the affected gene was COL2A1 in 11, ACAN in 1, and SLC26A2 in 1. After familial segregation analysis, 20 additional individuals were identified. The mean ± SD age at onset of joint pain was 19.5 ± 3.9 years (95% confidence interval 3-47). Eighteen of 33 subjects (55%) with nonsyndromic early-onset OA and a genetic variant had had at least 1 joint replacement (mean ± SD age at first joint replacement 41 ± 4.2 years; mean number of joint replacements 2.6 per individual), and 21 (45%) of the joint replacement surgeries were performed when the patient was <45 years old. Of the 20 patients age >40 years, 17 (85%) had had at least 1 joint replacement., Conclusion: We confirmed that COL2A1 is the main monogenic cause of nonsyndromic early-onset OA. However, on the basis of genetic heterogeneity of early-onset OA, we recommend next-generation sequencing for all individuals who undergo joint replacement prior to the age of 45 years. Lifestyle recommendations for prevention should be implemented., (© 2020, American College of Rheumatology.)- Published
- 2020
- Full Text
- View/download PDF
117. Differential Accumulation and Activation of Monocyte and Dendritic Cell Subsets in Inflamed Synovial Fluid Discriminates Between Juvenile Idiopathic Arthritis and Septic Arthritis.
- Author
-
Cren M, Nziza N, Carbasse A, Mahe P, Dufourcq-Lopez E, Delpont M, Chevassus H, Khalil M, Mura T, Duroux-Richard I, Apparailly F, Jeziorski E, and Louis-Plence P
- Subjects
- Adolescent, Biomarkers analysis, Child, Child, Preschool, Female, Humans, Immunophenotyping, Infant, Male, Arthritis, Infectious immunology, Arthritis, Juvenile immunology, Dendritic Cells immunology, Monocytes immunology, Synovial Fluid immunology
- Abstract
Despite their distinct etiology, several lines of evidence suggest that innate immunity plays a pivotal role in both juvenile idiopathic arthritis (JIA) and septic arthritis (SA) pathophysiology. Indeed, monocytes and dendritic cells (DC) are involved in the first line of defense against pathogens and play a critical role in initiating and orchestrating the immune response. The aim of this study was to compare the number and phenotype of monocytes and DCs in peripheral blood (PB) and synovial fluid (SF) from patients with JIA and SA to identify specific cell subsets and activation markers associated with pathophysiological mechanisms and that could be used as biomarkers to discriminate both diseases. The proportion of intermediate and non-classical monocytes in the SF and PB, respectively, were significantly higher in JIA than in SA patients. In contrast the proportion of classical monocytes and their absolute numbers were higher in the SF from SA compared with JIA patients. Higher expression of CD64 on non-classical monocyte was observed in PB from SA compared with JIA patients. In SF, higher expression of CD64 on classical and intermediate monocyte as well as higher CD163 expression on intermediate monocytes was observed in SA compared with JIA patients. Moreover, whereas the number of conventional (cDC), plasmacytoid (pDC) and inflammatory (infDC) DCs was comparable between groups in PB, the number of CD141
+ cDCs and CD123+ pDCs in the SF was significantly higher in JIA than in SA patients. CD14+ infDCs represented the major DC subset in the SF of both groups with potent activation assessed by high expression of HLA-DR and CD86 and significant up-regulation of HLA-DR expression in SA compared with JIA patients. Finally, higher activation of SF DC subsets was monitored in SA compared with JIA with significant up-regulation of CD86 and PDL2 expression on several DC subsets. Our results show the differential accumulation and activation of innate immune cells between septic and inflammatory arthritis. They strongly indicate that the relative high numbers of CD141+ cDC and CD123+ pDCs in SF are specific for JIA while the over-activation of DC and monocyte subsets is specific for SA., (Copyright © 2020 Cren, Nziza, Carbasse, Mahe, Dufourcq-Lopez, Delpont, Chevassus, Khalil, Mura, Duroux-Richard, Apparailly, Jeziorski and Louis-Plence.)- Published
- 2020
- Full Text
- View/download PDF
118. Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1 .
- Author
-
Madel MB, Ibáñez L, Ciucci T, Halper J, Rouleau M, Boutin A, Hue C, Duroux-Richard I, Apparailly F, Garchon HJ, Wakkach A, and Blin-Wakkach C
- Subjects
- Animals, Bone Resorption immunology, Bone Resorption pathology, Bone Resorption prevention & control, CX3C Chemokine Receptor 1 genetics, Cell Communication, Cells, Cultured, Female, Inflammation immunology, Inflammation pathology, Inflammation prevention & control, Mice, Inbred C57BL, Mice, Knockout, Osteoclasts immunology, Osteoclasts pathology, Osteoporosis immunology, Osteoporosis pathology, Osteoporosis prevention & control, Ovariectomy, Phenotype, Signal Transduction, T-Lymphocytes, Regulatory immunology, T-Lymphocytes, Regulatory metabolism, Tumor Necrosis Factor-alpha metabolism, Bone Resorption metabolism, CX3C Chemokine Receptor 1 metabolism, Inflammation metabolism, Osteoclasts metabolism, Osteogenesis, Osteoporosis metabolism
- Abstract
Bone destruction relies on interactions between bone and immune cells. Bone-resorbing osteoclasts (OCLs) were recently identified as innate immune cells activating T cells toward tolerance or inflammation. Thus, pathological bone destruction not only relies on increased osteoclast differentiation, but also on the presence of inflammatory OCLs (i-OCLs), part of which express Cx3cr1 . Here, we investigated the contribution of mouse Cx3cr1
+ and Cx3cr1neg i-OCLs to bone loss. We showed that Cx3cr1+ and Cx3cr1neg i-OCLs differ considerably in transcriptional and functional aspects. Cx3cr1neg i-OCLs have a high ability to resorb bone and activate inflammatory CD4+ T cells. Although Cx3cr1+ i-OCLs are associated with inflammation, they resorb less and have in vitro an immune-suppressive effect on Cx3cr1neg i-OCLs, mediated by PD-L1. Our results provide new insights into i-OCL heterogeneity. They also reveal that different i-OCL subsets may interact to regulate inflammation. This contributes to a better understanding and prevention of inflammatory bone destruction., Competing Interests: MM, LI, TC, JH, MR, AB, CH, ID, FA, HG, AW, CB No competing interests declared- Published
- 2020
- Full Text
- View/download PDF
119. POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4.
- Author
-
Sanchez E, Laplace-Builhé B, Mau-Them FT, Richard E, Goldenberg A, Toler TL, Guignard T, Gatinois V, Vincent M, Blanchet C, Boland A, Bihoreau MT, Deleuze JF, Olaso R, Nephi W, Lüdecke HJ, Verheij JBGM, Moreau-Lenoir F, Denoyelle F, Rivière JB, Laplanche JL, Willing M, Captier G, Apparailly F, Wieczorek D, Collet C, Djouad F, and Geneviève D
- Subjects
- Animals, Apoptosis genetics, Cell Differentiation genetics, Cell Movement genetics, Craniofacial Abnormalities pathology, Genetic Predisposition to Disease, Humans, Mandibulofacial Dysostosis pathology, Mutation, Neural Crest abnormalities, Neural Crest pathology, Tumor Suppressor Protein p53 genetics, Exome Sequencing, Zebrafish genetics, Craniofacial Abnormalities genetics, DNA-Directed RNA Polymerases genetics, Mandibulofacial Dysostosis genetics, Nuclear Proteins genetics, Phosphoproteins genetics
- Abstract
Purpose: Treacher Collins syndrome (TCS) is a rare autosomal dominant mandibulofacial dysostosis, with a prevalence of 0.2-1/10,000. Features include bilateral and symmetrical malar and mandibular hypoplasia and facial abnormalities due to abnormal neural crest cell (NCC) migration and differentiation. To date, three genes have been identified: TCOF1, POLR1C, and POLR1D. Despite a large number of patients with a molecular diagnosis, some remain without a known genetic anomaly., Methods: We performed exome sequencing for four individuals with TCS but who were negative for pathogenic variants in the known causative genes. The effect of the pathogenic variants was investigated in zebrafish., Results: We identified three novel pathogenic variants in POLR1B. Knockdown of polr1b in zebrafish induced an abnormal craniofacial phenotype mimicking TCS that was associated with altered ribosomal gene expression, massive p53-associated cellular apoptosis in the neuroepithelium, and reduced number of NCC derivatives., Conclusion: Pathogenic variants in the RNA polymerase I subunit POLR1B might induce massive p53-dependent apoptosis in a restricted neuroepithelium area, altering NCC migration and causing cranioskeletal malformations. We identify POLR1B as a new causative gene responsible for a novel TCS syndrome (TCS4) and establish a novel experimental model in zebrafish to study POLR1B-related TCS.
- Published
- 2020
- Full Text
- View/download PDF
120. PSMB10, the last immunoproteasome gene missing for PRAAS.
- Author
-
Sarrabay G, Méchin D, Salhi A, Boursier G, Rittore C, Crow Y, Rice G, Tran TA, Cezar R, Duffy D, Bondet V, Boudhane L, Broca C, Kant BP, VanGijn M, Grandemange S, Richard E, Apparailly F, and Touitou I
- Subjects
- Child, Preschool, Female, Humans, Mutation, Autoimmune Diseases genetics, Proteasome Endopeptidase Complex genetics
- Published
- 2020
- Full Text
- View/download PDF
121. Arthritis sensory and motor scale: predicting functional deficits from the clinical score in collagen-induced arthritis.
- Author
-
Mausset-Bonnefont AL, Cren M, Vicente R, Quentin J, Jorgensen C, Apparailly F, and Louis-Plence P
- Subjects
- Animals, Antirheumatic Agents pharmacology, Inflammation etiology, Locomotion physiology, Male, Methotrexate pharmacology, Mice, Pain etiology, Skin Temperature, Arthritis, Experimental complications, Arthritis, Rheumatoid complications
- Abstract
Background: In the collagen-induced arthritis (CIA) mouse model, inflammation readouts are usually quantified using operator-dependent clinical scoring systems, and no systematic relationship with functional deficits has been detected. In this study, we extensively quantified sensory and motor deficits in CIA mice during natural disease progression and therapeutic treatment. Then, we used these data to build a scale to predict functional deficits on the basis of the classical clinical score., Methods: Using the CIA mouse model, we longitudinally screened multiple approaches to assess locomotion (open field test, Catwalk™), sensitivity (Von Frey, Hargreaves, static weight-bearing tests), and inflammation (skin temperature), and identified the most accurate tests to correlate sensory and motor deficits with disease severity, measured by clinical score. We then used these tests to characterize functional deficits in control (naïve and mice injected with complete Freund's adjuvant) and CIA mice, either untreated or treated with methotrexate to prevent functional deficits. By mathematical approaches, we finally investigated the relationship between functional deficits and clinical score., Results: We found that the functional disability scores obtained with the open field, Catwalk™, Hargreaves, and skin temperature tests significantly correlated with the clinical score in CIA mice, either untreated or treated with methotrexate. Mathematical correlation showed that motor deficits, robustly characterized by two different tests, were twice more responsive than thermal sensitivity deficits., Conclusion: We propose the arthritis sensory and motor (ArthriSM) scale as a new theranostic tool to predict motor and sensory deficit based on the clinical score, in the experimental mouse model of CIA. This ArthriSM scale may facilitate the transfer of knowledge between preclinical and clinical studies.
- Published
- 2019
- Full Text
- View/download PDF
122. Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis.
- Author
-
Nziza N, Jeziorski E, Delpont M, Cren M, Chevassus H, Carbasse A, Mahe P, Abassi H, Joly-Monrigal P, Schordan E, Mangé A, Jorgensen C, Apparailly F, and Duroux-Richard I
- Subjects
- Arthritis, Juvenile metabolism, Biomarkers, Computational Biology methods, Female, Gene Expression Profiling, Gene Expression Regulation, Humans, Liquid Biopsy, Male, MicroRNAs blood, MicroRNAs metabolism, Prognosis, Signal Transduction, Arthritis, Juvenile diagnosis, Arthritis, Juvenile genetics, Circulating MicroRNA, MicroRNAs genetics, Synovial Fluid metabolism
- Abstract
Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory rheumatism in childhood; microRNAs (miRNAs) have been proposed as diagnostic biomarkers. Although joints are the primary targets for JIA, a synovial fluid-based miRNA signature has never been studied. We aim to identify miRNA biomarkers in JIA by comparing synovial fluid and serum samples from children with JIA and K. kingae septic arthritis (SA). With next-generation high-throughput sequencing, we measured the absolute levels of 2083 miRNAs in synovial fluid and serum from an exploratory cohort of children and validated differentially expressed miRNAs in a replication study by using RT-qPCR. We identified a 19-miRNA signature only in synovial fluid samples that was significantly deregulated, with at least 2-fold change in expression, in JIA versus SA (p < 0.01). The combination of miR-6764-5p, miR-155, and miR-146a-5p expression in synovial fluid yielded an area under the receiver operating characteristic curve of 1 (95% CI 0.978 to 1), thereby perfectly differentiating JIA from SA in children. We propose, for the first time, a synovial fluid-specific miRNA signature for JIA and associated signaling pathways that may indicate potential biomarkers to assist in the classification and differential diagnosis of JIA and help in understanding JIA pathogenesis., Competing Interests: The authors declare no conflict of interest
- Published
- 2019
- Full Text
- View/download PDF
123. MicroRNAs: Fine Tuners of Monocyte Heterogeneity.
- Author
-
Duroux-Richard I, Robin M, Peillex C, and Apparailly F
- Subjects
- Animals, Humans, MicroRNAs immunology, Monocytes immunology
- Abstract
Small non-coding microRNAs (miRNAs) have been found to play critical roles in many biological processes by controlling gene expression at the post-transcriptional level. They appear to fine-tune the immune response by targeting key regulatory molecules, and their abnormal expression is associated with immune-mediated inflammatory disorders. Monocytes actively contribute to tissue homeostasis by triggering acute inflammatory reactions as well as the resolution of inflammation and tissue regeneration, in case of injury or pathogen invasion. Their contribution to tissue homeostasis can have many aspects because they are able to differentiate into different cell types including macrophages, dendritic cells, and osteoclasts, which fulfill functions as different as bone remodeling and immune response. Monocytes consist of different subsets with subset-specific expression of miRNAs linked to distinct biological processes dedicated to specific roles. Therefore, understanding the role of miRNAs in the context of monocyte heterogeneity may provide clues as to which subset gives rise to which cell type in tissues. In addition, because monocytes are involved in the pathogenesis of chronic inflammation, associated with loss of tissue homeostasis and function, identifying subset-specific miRNAs might help in developing therapeutic strategies that target one subset while sparing the others. Here, we give an overview of the state-of-the-art research regarding miRNAs that are differentially expressed between monocyte subsets and how they influence monocyte functional heterogeneity in health and disease, with descriptions of specific miRNAs. We also revisit the existing miRNome data to propose a canonical signature for each subset., (Copyright © 2019 Duroux-Richard, Robin, Peillex and Apparailly.)
- Published
- 2019
- Full Text
- View/download PDF
124. MicroRNAs in juvenile idiopathic arthritis: Can we learn more about pathophysiological mechanisms?
- Author
-
Nziza N, Duroux-Richard I, and Apparailly F
- Subjects
- Animals, Humans, Arthritis, Juvenile genetics, Arthritis, Juvenile immunology, MicroRNAs immunology
- Abstract
Juvenile idiopathic arthritis (JIA) is a heterogeneous and multifactorial group of chronic arthritis with an onset before the age of 16 years. The pathogenesis of this disease is poorly understood, which makes the distinction among subtypes unclear, delays diagnosis and optimal therapeutic management. MicroRNAs (miRNAs) are small non-coding RNAs that play a critical role in the regulation of immune responses. Their expression is tightly controlled to ensure cellular homeostasis and function of innate and adaptive immune cells. Abnormal expression of miRNAs has been associated with the development of many inflammatory and autoimmune diseases. In this review, we gather results published on miRNAs expression profiles in JIA patients with the aim to identify miRNAs that can be used as diagnostic biomarkers and provide information on disease activity and progression. We also focus on miRNAs deregulated in different forms of JIA to shed light on common pathways potentially involved in disease pathophysiology., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
125. Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions.
- Author
-
Madel MB, Ibáñez L, Wakkach A, de Vries TJ, Teti A, Apparailly F, and Blin-Wakkach C
- Subjects
- Animals, Antigen Presentation, Biomarkers, Bone Remodeling immunology, Bone Resorption immunology, Bone Resorption metabolism, Cell Differentiation, Dendritic Cells immunology, Dendritic Cells metabolism, Humans, Lymphocyte Activation immunology, Macrophages immunology, Macrophages metabolism, Monocytes immunology, Monocytes metabolism, Osteoclasts pathology, Phenotype, Disease Susceptibility, Immunomodulation, Osteoclasts immunology, Osteoclasts metabolism
- Abstract
Osteoclasts (OCLs) are key players in controlling bone remodeling. Modifications in their differentiation or bone resorbing activity are associated with a number of pathologies ranging from osteopetrosis to osteoporosis, chronic inflammation and cancer, that are all characterized by immunological alterations. Therefore, the 2000s were marked by the emergence of osteoimmunology and by a growing number of studies focused on the control of OCL differentiation and function by the immune system. At the same time, it was discovered that OCLs are much more than bone resorbing cells. As monocytic lineage-derived cells, they belong to a family of cells that displays a wide heterogeneity and plasticity and that is involved in phagocytosis and innate immune responses. However, while OCLs have been extensively studied for their bone resorption capacity, their implication as immune cells was neglected for a long time. In recent years, new evidence pointed out that OCLs play important roles in the modulation of immune responses toward immune suppression or inflammation. They unlocked their capacity to modulate T cell activation, to efficiently process and present antigens as well as their ability to activate T cell responses in an antigen-dependent manner. Moreover, similar to other monocytic lineage cells such as macrophages, monocytes and dendritic cells, OCLs display a phenotypic and functional plasticity participating to their anti-inflammatory or pro-inflammatory effect depending on their cell origin and environment. This review will address this novel vision of the OCL, not only as a phagocyte specialized in bone resorption, but also as innate immune cell participating in the control of immune responses.
- Published
- 2019
- Full Text
- View/download PDF
126. MicroRNAs: Key Regulators to Understand Osteoclast Differentiation?
- Author
-
Lozano C, Duroux-Richard I, Firat H, Schordan E, and Apparailly F
- Subjects
- Animals, Humans, Osteoclasts cytology, Stem Cells cytology, Antigens, Differentiation immunology, Cell Differentiation immunology, MicroRNAs immunology, Osteoclasts immunology, Signal Transduction immunology, Stem Cells immunology
- Abstract
MicroRNAs (miRNAs) are small non-coding single-stranded RNAs that represent important posttranscriptional regulators of protein-encoding genes. In particular, miRNAs play key roles in regulating cellular processes such as proliferation, migration, and cell differentiation. Recently, miRNAs emerged as critical regulators of osteoclasts (OCs) biology and have been involved in OCs pathogenic role in several disorders. OCs are multinucleated cells generated from myeloid precursors in the bone marrow, specialized in bone resorption. While there is a growing number of information on the cytokines and signaling pathways that are critical to control the differentiation of osteoclast precursors (OCPs) into mature OCs, the connection between OC differentiation steps and miRNAs is less well-understood. The present review will first summarize our current understanding of the miRNA-regulated pathways in the sequential steps required for OC formation, from the motility and migration of OCPs to the cell-cell fusion and the final formation of the actin ring and ruffled border in the functionally resorbing multinucleated OCs. Then, considering the difficulty of working on primary OCs and on the generation of robust data we will give an update on the most recent advances in the detection technologies for miRNAs quantification and how these are of particular interest for the understanding of OC biology and their use as potential biomarkers.
- Published
- 2019
- Full Text
- View/download PDF
127. LARP7 variants and further delineation of the Alazami syndrome phenotypic spectrum among primordial dwarfisms: 2 sisters.
- Author
-
Imbert-Bouteille M, Mau Them FT, Thevenon J, Guignard T, Gatinois V, Riviere JB, Boland A, Meyer V, Deleuze JF, Sanchez E, Apparailly F, Geneviève D, and Willems M
- Subjects
- Child, Dwarfism pathology, Female, Humans, Intellectual Disability pathology, Loss of Function Mutation, Microcephaly pathology, Siblings, Syndrome, Dwarfism genetics, Intellectual Disability genetics, Microcephaly genetics, Phenotype, Ribonucleoproteins genetics
- Abstract
Alazami syndrome (AS) (MIM# 615071) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in LARP7. To date, 15 patients with AS have been reported. Here we describe two consanguineous Algerian sisters with Alazami PD due to LARP7 homozygous pathogenic variants detected by whole exome sequencing. By comparing these two additional cases with those previously reported, we strengthen the key features of AS: severe growth restriction, severe intellectual disability and some distinguishing facial features such as broad nose, malar hypoplasia, wide mouth, full lips and abnormally set teeth. We also report significant new findings enabling further delineation of this syndrome: disproportionately mild microcephaly, stereotypic hand wringing and severe anxiety, thickened skin over the hands and feet, and skeletal, eye and heart malformations. From previous reviews, we summarize the main etiologies of PD according to the involved mechanisms and cellular pathways, highlighting their clinical core features., (Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
128. Delivery of miR-146a to Ly6C high Monocytes Inhibits Pathogenic Bone Erosion in Inflammatory Arthritis.
- Author
-
Ammari M, Presumey J, Ponsolles C, Roussignol G, Roubert C, Escriou V, Toupet K, Mausset-Bonnefont AL, Cren M, Robin M, Georgel P, Nehmar R, Taams L, Grün J, Grützkau A, Häupl T, Pers YM, Jorgensen C, Duroux-Richard I, Courties G, and Apparailly F
- Subjects
- Animals, Arthritis chemically induced, Arthritis therapy, Arthritis, Rheumatoid pathology, Disease Models, Animal, Flow Cytometry, Humans, Mice, Inbred C57BL, Mice, Inbred DBA, Mice, Knockout, MicroRNAs administration & dosage, Monocytes chemistry, Antigens, Ly analysis, Arthritis pathology, Bone and Bones pathology, Cell Differentiation, MicroRNAs analysis, Monocytes physiology, Osteoclasts physiology
- Abstract
Rationale: Monocytes play critical roles in the pathogenesis of arthritis by contributing to the inflammatory response and bone erosion. Among genes involved in regulating monocyte functions, miR-146a negatively regulates the inflammatory response and osteoclast differentiation of monocytes. It is also the only miRNA reported to differentially regulate the cytokine response of the two classical Ly6C
high and non-classical Ly6Clow monocyte subsets upon bacterial challenge. Although miR-146a is overexpressed in many tissues of arthritic patients, its specific role in monocyte subsets under arthritic conditions remains to be explored. Methods: We analyzed the monocyte subsets during collagen-induced arthritis (CIA) development by flow cytometry. We quantified the expression of miR-146a in classical and non-classical monocytes sorted from healthy and CIA mice, as well as patients with rheumatoid arthritis (RA). We monitored arthritis features in miR-146a-/- mice and assessed in vivo the therapeutic potential of miR-146a mimics delivery to Ly6Chigh monocytes. We performed transcriptomic and pathway enrichment analyses on both monocyte subsets sorted from wild type and miR-146a-/- mice. Results: We showed that the expression of miR-146a is reduced in the Ly6Chigh subset of CIA mice and in the analogous monocyte subset (CD14+ CD16- ) in humans with RA as compared with healthy controls. The ablation of miR-146a in mice worsened arthritis severity, increased osteoclast differentiation in vitro and bone erosion in vivo . In vivo delivery of miR-146a to Ly6Chigh monocytes, and not to Ly6Clow monocytes, rescues bone erosion in miR-146a-/- arthritic mice and reduces osteoclast differentiation and pathogenic bone erosion in CIA joints of miR-146a+/+ mice, with no effect on inflammation. Silencing of the non-canonical NF-κB family member RelB in miR-146a-/- Ly6Chigh monocytes uncovers a role for miR-146a as a key regulator of the differentiation of Ly6Chigh , and not Ly6Clow , monocytes into osteoclasts under arthritic conditions. Conclusion: Our results show that classical monocytes play a critical role in arthritis bone erosion. They demonstrate the theranostics potential of manipulating miR-146a expression in Ly6Chigh monocytes to prevent joint destruction while sparing inflammation in arthritis., Competing Interests: Competing Interests: The authors have declared that no competing interest exists.- Published
- 2018
- Full Text
- View/download PDF
129. Advanced microRNA-based cancer diagnostics using amplified time-gated FRET.
- Author
-
Qiu X, Xu J, Guo J, Yahia-Ammar A, Kapetanakis NI, Duroux-Richard I, Unterluggauer JJ, Golob-Schwarzl N, Regeard C, Uzan C, Gouy S, DuBow M, Haybaeck J, Apparailly F, Busson P, and Hildebrandt N
- Abstract
MicroRNAs (miRNAs) play an important role in cellular functions and in the development and progression of cancer. Precise quantification of endogenous miRNAs from different clinical patient and control samples combined with a one-to-one comparison to standard technologies is a challenging but necessary endeavor that is largely neglected by many emerging fluorescence technologies. Here, we present a simple, precise, sensitive, and specific ratiometric assay for absolute quantification of miRNAs. Isothermally amplified time-gated Förster resonance energy transfer (TG-FRET) between Tb donors and dye acceptors resulted in miRNA assays with single-nucleotide variant specificity and detection limits down to 4.2 ± 0.5 attomoles. Quantification of miR-21 from human tissues and plasma samples revealed the relevance for breast and ovarian cancer diagnostics. Analysis of miR-132 and miR-146a from acute monocytic leukemia cells (THP-1) demonstrated the broad applicability to different miRNAs and other types of clinical samples. Direct comparison to the gold standard RT-qPCR showed advantages of amplified TG-FRET concerning precision and specificity when quantifying low concentrations of miRNAs as required for diagnostic applications. Our results demonstrate that a careful implementation of rolling circle amplification and TG-FRET into one straightforward nucleic acid detection method can significantly advance the possibilities of miRNA-based cancer diagnostics and research.
- Published
- 2018
- Full Text
- View/download PDF
130. Beneficial Effect of Alcohol Withdrawal on Gut Permeability and Microbial Translocation in Patients with Alcohol Use Disorder.
- Author
-
Donnadieu-Rigole H, Pansu N, Mura T, Pelletier S, Alarcon R, Gamon L, Perney P, Apparailly F, Lavigne JP, and Dunyach-Remy C
- Subjects
- Adult, Alcoholism microbiology, Alcoholism therapy, Female, Humans, Male, Middle Aged, Substance Withdrawal Syndrome microbiology, Substance Withdrawal Syndrome therapy, Alcohol Abstinence trends, Alcoholism diagnosis, Bacterial Translocation physiology, Gastrointestinal Absorption physiology, Gastrointestinal Microbiome physiology, Substance Withdrawal Syndrome diagnosis
- Abstract
Background: The human intestinal microbiota exerts beneficial or harmful effects in several disorders. Many factors, including alcohol consumption, may influence its composition and trigger bacterial translocation. Excessive alcohol consumption increases gut permeability and translocation of endotoxin into peripheral circulation. Although plasma endotoxin concentrations have been measured often, quantitative changes following alcohol withdrawal have never been described in subjects with alcohol use disorder (AUD). The aim of this study was to measure microbial translocation (MT) and gut permeability markers in patients with AUD, to compare these markers to healthy controls (HC) and to monitor markers during the first 6 weeks of abstinence., Methods: Sixty-five patients with AUD and hospitalized for alcohol withdrawal were included. Epidemiological, clinical, biological, and addictological data were gathered. Blood samples were collected at baseline, then 3 and 6 weeks after alcohol withdrawal. A hundred healthy volunteers were used as controls. Three markers of MT were monitored in plasma samples: sCD14 and lipopolysaccharide-binding protein (LBP) were quantified using ELISA, and 16S rDNA was quantified using real-time polymerase chain reaction. Zonulin and intestinal fatty acid binding protein (I-FABP) blood levels were also monitored as indirect markers of gut permeability, using ELISA., Results: At baseline, LBP, 16S rDNA, sCD14 and I-FABP markers were significantly higher in patients with AUD than in HC. Six weeks after alcohol withdrawal plasma levels of sCD14 and LBP decreased significantly. Cannabis consumption and body mass index (BMI) before alcohol withdrawal influenced baseline MT levels and the decrease in MT markers after 6 weeks. Finally, markers of MT and gut permeability did not correlate with each other before and after alcohol withdrawal., Conclusions: Before alcohol withdrawal, MT markers were higher in patients with AUD than in HC. After 6 weeks of abstinence, an improvement in MT markers was observed. Our data suggest that there is a link between MT, its improvement, BMI, and cannabis consumption., (Copyright © 2017 by the Research Society on Alcoholism.)
- Published
- 2018
- Full Text
- View/download PDF
131. Regenerative medicine: Breaking Prometheus's curse for cartilage regeneration.
- Author
-
Apparailly F
- Subjects
- Cartilage, Regeneration, Stem Cells, Biological Products, Regenerative Medicine
- Published
- 2017
- Full Text
- View/download PDF
132. A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD ( NLRP1- associated autoinflammation with arthritis and dyskeratosis).
- Author
-
Grandemange S, Sanchez E, Louis-Plence P, Tran Mau-Them F, Bessis D, Coubes C, Frouin E, Seyger M, Girard M, Puechberty J, Costes V, Rodière M, Carbasse A, Jeziorski E, Portales P, Sarrabay G, Mondain M, Jorgensen C, Apparailly F, Hoppenreijs E, Touitou I, and Geneviève D
- Subjects
- Adolescent, Algeria, Arthritis, Juvenile complications, Arthritis, Juvenile immunology, Autoimmune Diseases complications, Autoimmune Diseases immunology, B-Lymphocytes immunology, Black People, Caspase 1 immunology, Child, Consanguinity, Female, Hereditary Autoinflammatory Diseases complications, Hereditary Autoinflammatory Diseases immunology, Homozygote, Humans, Interleukin-18 immunology, Male, Mutation, NLR Proteins, Netherlands, Precursor Cells, B-Lymphoid immunology, Skin Diseases complications, Skin Diseases immunology, Syndrome, White People, Adaptor Proteins, Signal Transducing genetics, Apoptosis Regulatory Proteins genetics, Arthritis, Juvenile genetics, Autoimmune Diseases genetics, Hereditary Autoinflammatory Diseases genetics, Skin Diseases genetics
- Abstract
Objectives: Inflammasomes are multiprotein complexes that sense pathogens and trigger biological mechanisms to control infection. Nucleotide-binding oligomerisation domain-like receptor (NLR) containing a PYRIN domain 1 (NLRP1), NLRP3 and NLRC4 plays a key role in this innate immune system by directly assembling in inflammasomes and regulating inflammation. Mutations in NLRP3 and NLRC4 are linked to hereditary autoinflammatory diseases, whereas polymorphisms in NLRP1 are associated with autoimmune disorders such as vitiligo and rheumatoid arthritis. Whether human NLRP1 mutation is associated with autoinflammation remains to be determined., Methods: To search for novel genes involved in systemic juvenile idiopathic arthritis, we performed homozygosity mapping and exome sequencing to identify causative genes. Immunoassays were performed with blood samples from patients., Results: We identified a novel disease in three patients from two unrelated families presenting diffuse skin dyskeratosis, autoinflammation, autoimmunity, arthritis and high transitional B-cell level. Molecular screening revealed a non-synonymous homozygous mutation in NLRP1 (c.2176C>T; p.Arg726Trp) in two cousins born of related parents originating from Algeria and a de novo heterozygous mutation (c.3641C>G, p.Pro1214Arg) in a girl of Dutch origin. The three patients showed elevated systemic levels of caspase-1 and interleukin 18, which suggested involvement of NLRP1 inflammasome., Conclusions: We demonstrate the responsibility of human NLRP1 in a novel autoinflammatory disorder that we propose to call NAIAD for NLRP1- associated autoinflammation with arthritis and dyskeratosis. This disease could be a novel autoimmuno-inflammatory disease combining autoinflammatory and autoimmune features. Our data, combined with that in the literature, highlight the pleomorphic role of NLRP1 in inflammation and immunity., Trial Registration Number: NCT02067962; Results., Competing Interests: Competing interests: None., (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.)
- Published
- 2017
- Full Text
- View/download PDF
133. miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study.
- Author
-
Gagez AL, Duroux-Richard I, Leprêtre S, Orsini-Piocelle F, Letestu R, De Guibert S, Tuaillon E, Leblond V, Khalifa O, Gouilleux-Gruart V, Banos A, Tournilhac O, Dupuis J, Jorgensen C, Cartron G, and Apparailly F
- Subjects
- Antineoplastic Combined Chemotherapy Protocols adverse effects, Biomarkers, Tumor, Cluster Analysis, Diagnosis, Differential, Female, Gene Expression Regulation, Leukemic, Genotype, Humans, Leukemia, Lymphocytic, Chronic, B-Cell diagnosis, Leukemia, Lymphocytic, Chronic, B-Cell mortality, Lymphocytosis diagnosis, Lymphocytosis genetics, Male, MicroRNAs blood, Middle Aged, Models, Biological, Prognosis, RNA Interference, Rituximab administration & dosage, Transcriptome, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Leukemia, Lymphocytic, Chronic, B-Cell drug therapy, Leukemia, Lymphocytic, Chronic, B-Cell genetics, Lymphocyte Depletion, MicroRNAs genetics
- Abstract
The underlying in vivo mechanisms of rituximab action remain incompletely understood in chronic lymphocytic leukemia. Recent data suggest that circulating micro-ribonucleic acids correlate with chronic lymphocytic leukemia progression and response to rituximab. Our study aimed at identifying circulating micro-ribonucleic acids that predict response to rituximab monotherapy in chronic lymphocytic leukemia patients. Using a hierarchical clustering of micro-ribonucleic acid expression profiles discriminating 10 untreated patients with low or high lymphocyte counts, we found 26 micro-ribonucleic acids significantly deregulated. Using individual real-time reverse transcription polymerase chain reaction, the expression levels of micro-ribonucleic acids representative of these two clusters were further validated in a larger cohort (n=61). MiR-125b and miR-532-3p were inversely correlated with rituximab-induced lymphodepletion ( P =0.020 and P =0.001, respectively) and with the CD20 expression on CD19
+ cells ( P =0.0007 and P <0.0001, respectively). In silico analyses of genes putatively targeted by both micro-ribonucleic acids revealed a central role of the interleukin-10 pathway and CD20 (MS4A1) family members. Interestingly, both micro-ribonucleic acids were negatively correlated with MS4A1 expression, while they were positively correlated with MS4A3 and MSA47 Our results identify novel circulating predictive biomarkers for rituximab-mediated lymphodepletion efficacy in chronic lymphocytic leukemia, and suggest a novel molecular mechanism responsible for the rituximab mode of action that bridges miR-125b and miR-532-3p and CD20 family members. ( clinicaltrials.gov Identifier: 01370772 )., (Copyright© Ferrata Storti Foundation.)- Published
- 2017
- Full Text
- View/download PDF
134. microRNA target prediction programs predict many false positives.
- Author
-
Pinzón N, Li B, Martinez L, Sergeeva A, Presumey J, Apparailly F, and Seitz H
- Subjects
- 3' Untranslated Regions genetics, Algorithms, Animals, Binding Sites, Computational Biology, Humans, Mice, MicroRNAs metabolism, Gene Expression Regulation genetics, MicroRNAs genetics, RNA, Messenger genetics
- Abstract
According to the current view, each microRNA regulates hundreds of genes. Computational tools aim at identifying microRNA targets, usually selecting evolutionarily conserved microRNA binding sites. While the false positive rates have been evaluated for some prediction programs, that information is rarely put forward in studies making use of their predictions. Here, we provide evidence that such predictions are often biologically irrelevant. Focusing on miR-223-guided repression, we observed that it is often smaller than inter-individual variability in gene expression among wild-type mice, suggesting that most predicted targets are functionally insensitive to that microRNA. Furthermore, we found that human haplo-insufficient genes tend to bear the most highly conserved microRNA binding sites. It thus appears that biological functionality of microRNA binding sites depends on the dose-sensitivity of their host gene and that, conversely, it is unlikely that every predicted microRNA target is dose-sensitive enough to be functionally regulated by microRNAs. We also observed that some mRNAs can efficiently titrate microRNAs, providing a reason for microRNA binding site conservation for inefficiently repressed targets. Finally, many conserved microRNA binding sites are conserved in a microRNA-independent fashion: Sequence elements may be conserved for other reasons, while being fortuitously complementary to microRNAs. Collectively, our data suggest that the role of microRNAs in normal and pathological conditions has been overestimated due to the frequent overlooking of false positive rates., (© 2017 Pinzón et al.; Published by Cold Spring Harbor Laboratory Press.)
- Published
- 2017
- Full Text
- View/download PDF
135. TMEM187-IRAK1 Polymorphisms Associated with Rheumatoid Arthritis Susceptibility in Tunisian and French Female Populations: Influence of Geographic Origin.
- Author
-
Khalifa O, Balandraud N, Lambert N, Auger I, Roudier J, Sénéchal A, Geneviève D, Picard C, Lefranc G, Touitou I, Mrenda BM, Benedito C, Pardoux E, Gagez AL, Pers YM, Jorgensen C, Mahjoub T, and Apparailly F
- Subjects
- Adult, Aged, Alleles, Arthritis, Rheumatoid epidemiology, Disease Susceptibility, Female, France epidemiology, Geography, HLA-DR Antigens genetics, HLA-DRB1 Chains, Haplotypes genetics, Humans, Meta-Analysis as Topic, Middle Aged, Tunisia epidemiology, Arthritis, Rheumatoid ethnology, Arthritis, Rheumatoid genetics, Chromosomes, Human, X genetics, Genetic Predisposition to Disease, Interleukin-1 Receptor-Associated Kinases genetics, Membrane Proteins genetics, Polymorphism, Single Nucleotide
- Abstract
Polymorphisms have been identified in the Xq28 locus as risk loci for rheumatoid arthritis (RA). Here, we investigated the association between three polymorphisms in the Xq28 region containing TMEM187 and IRAK1 (rs13397, rs1059703, and rs1059702) in two unstudied populations: Tunisian and French. The rs13397 G and rs1059703 T major alleles were significantly increased in RA patients ( n = 408) compared with age-matched controls ( n = 471) in both Tunisian and French women. These results were confirmed by a meta-analysis replication study including two independent Greek and Korean cohorts. The rs1059702 C major allele was significantly associated with RA, only with French women. In the French population, the GTC haplotype displayed a protective effect against RA, while the ATC, GCC, and GTT haplotypes conferred significant risk for RA. No association for these haplotypes was found in the Tunisian population. Our results replicated for the first time the association of the three Xq28 polymorphisms with RA risk in Tunisian and French populations and suggested that RA susceptibility is associated with TMEM187-IRAK1 polymorphisms in women. Our data further support the involvement of X chromosome in RA susceptibility and evidence ethnicities differences that might be explained by differences in the frequencies of SE HLA-DRB1 alleles between both populations., Competing Interests: The authors declaring that they have no competing interests are Olfa Khalifa, Nathalie Balandraud, Nathalie Lambert, Isabelle Auger, Jean Roudier, Audrey Sénéchal, David Geneviève, Christophe Picard, Gérard Lefranc, Hicham Charoute, Isabelle Touitou, Bakridine M'Madi Mrenda, Cécilia Benedito, Etienne Pardoux, Anne-Laure Gagez, Yves-Marie Pers, Christian Jorgensen, Touhami Mahjoub, and Florence Apparailly.
- Published
- 2017
- Full Text
- View/download PDF
136. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
- Author
-
Duroux-Richard I, Giovannangeli C, and Apparailly F
- Subjects
- Animals, Gene Editing, Genetic Engineering methods, Genetic Therapy methods, Genome, Humans, RNA Editing, Rheumatic Diseases therapy, Sensitivity and Specificity, CRISPR-Cas Systems genetics, Clustered Regularly Interspaced Short Palindromic Repeats genetics, Gene Targeting methods, Genomics methods, Rheumatic Diseases genetics
- Published
- 2017
- Full Text
- View/download PDF
137. miR-125b controls monocyte adaptation to inflammation through mitochondrial metabolism and dynamics.
- Author
-
Duroux-Richard I, Roubert C, Ammari M, Présumey J, Grün JR, Häupl T, Grützkau A, Lecellier CH, Boitez V, Codogno P, Escoubet J, Pers YM, Jorgensen C, and Apparailly F
- Subjects
- Aged, Apoptosis genetics, Apoptosis Regulatory Proteins genetics, Apoptosis Regulatory Proteins metabolism, Cell Polarity genetics, Cell Respiration genetics, Female, Gene Expression Regulation, Gene Silencing, HEK293 Cells, Humans, Lipopolysaccharide Receptors metabolism, Macrophages metabolism, Macrophages pathology, Male, Membrane Proteins genetics, Membrane Proteins metabolism, MicroRNAs genetics, Mitochondrial Proteins genetics, Mitochondrial Proteins metabolism, Models, Biological, Toll-Like Receptor 4 metabolism, Inflammation genetics, Inflammation pathology, MicroRNAs metabolism, Mitochondria metabolism, Mitochondrial Dynamics genetics, Monocytes metabolism, Monocytes pathology
- Abstract
Metabolic changes drive monocyte differentiation and fate. Although abnormal mitochondria metabolism and innate immune responses participate in the pathogenesis of many inflammatory disorders, molecular events regulating mitochondrial activity to control life and death in monocytes remain poorly understood. We show here that, in human monocytes, microRNA-125b (miR-125b) attenuates the mitochondrial respiration through the silencing of the BH3-only proapoptotic protein BIK and promotes the elongation of the mitochondrial network through the targeting of the mitochondrial fission process 1 protein MTP18, leading to apoptosis. Proinflammatory activation of monocyte-derived macrophages is associated with a concomitant increase in miR-125b expression and decrease in BIK and MTP18 expression, which lead to reduced oxidative phosphorylation and enhanced mitochondrial fusion. In a chronic inflammatory systemic disorder, CD14
+ blood monocytes display reduced miR-125b expression as compared with healthy controls, inversely correlated with BIK and MTP18 messenger RNA expression. Our findings not only identify BIK and MTP18 as novel targets for miR-125b that control mitochondrial metabolism and dynamics, respectively, but also reveal a novel function for miR-125b in regulating metabolic adaptation of monocytes to inflammation. Together, these data unravel new molecular mechanisms for a proapoptotic role of miR-125b in monocytes and identify potential targets for interfering with excessive inflammatory activation of monocytes in inflammatory disorders., (© 2016 by The American Society of Hematology.)- Published
- 2016
- Full Text
- View/download PDF
138. X-Linked miRNAs Associated with Gender Differences in Rheumatoid Arthritis.
- Author
-
Khalifa O, Pers YM, Ferreira R, Sénéchal A, Jorgensen C, Apparailly F, and Duroux-Richard I
- Subjects
- Adult, Aged, Arthritis, Rheumatoid genetics, Arthritis, Rheumatoid metabolism, Arthritis, Rheumatoid pathology, Case-Control Studies, Female, Forkhead Transcription Factors metabolism, Gene Expression Regulation, Genetic Predisposition to Disease, Humans, Leukocytes, Mononuclear, Male, MicroRNAs metabolism, Middle Aged, Polymorphism, Single Nucleotide, Promoter Regions, Genetic, Quantitative Trait Loci, Sex Factors, Arthritis, Rheumatoid diagnosis, Chromosomes, Human, X, Forkhead Transcription Factors genetics, MicroRNAs genetics
- Abstract
Rheumatoid arthritis (RA) is an autoimmune disease that predominantly affects women. MicroRNAs have emerged as crucial regulators of the immune system, whose expression is deregulated in RA. We aimed at quantifying the expression level of 14 miRNAs located on the X chromosome and at identifying whether differences are associated with disease and/or sex. A case-control study of 21 RA patients and 22 age- and sex-matched healthy controls was performed on peripheral blood mononuclear cells. The expression level of five miRNAs (miR-221, miR-222, miR-532, miR-106a, and miR-98) was significantly different between RA and controls when stratifying by sex, and the expression level of four miRNAs (miR-222, miR-532, miR-98, and miR-92a) was significantly different between RA females and males. The expression quantitative trait loci (eQTL) analysis revealed a significant gender effect of the FoxP3 promoter polymorphism rs3761548A/C on miR-221, miR-222 and miR-532 expression levels, and of the FoxP3 polymorphism rs2232365A/G on miR-221 expression levels in PBMC of RA patients. These data further support the involvement of the X chromosome in RA susceptibility. X-linked miRNAs, in the context of sex differences, might provide novel insight into new molecular mechanisms and potential therapeutic targets in RA for disease treatment and prevention., Competing Interests: The authors declare no conflict of interest.
- Published
- 2016
- Full Text
- View/download PDF
139. Effects of alcohol withdrawal on monocyte subset defects in chronic alcohol users.
- Author
-
Donnadieu-Rigole H, Mura T, Portales P, Duroux-Richard I, Bouthier M, Eliaou JF, Perney P, and Apparailly F
- Subjects
- Adult, Female, GPI-Linked Proteins analysis, Humans, Immunophenotyping, Interleukins biosynthesis, Interleukins blood, Lipopolysaccharide Receptors analysis, Lipopolysaccharides pharmacology, Male, Middle Aged, Monocytes chemistry, Monocytes classification, Monocytes drug effects, Peptidoglycan pharmacology, Receptors, IgG analysis, Toll-Like Receptor 2 blood, Toll-Like Receptor 4 blood, Tumor Necrosis Factor-alpha biosynthesis, Tumor Necrosis Factor-alpha blood, Alcoholism immunology, Ethanol adverse effects, Monocytes pathology, Substance Withdrawal Syndrome immunology
- Abstract
Excessive alcohol consumption has a modulating effect on immune functions that may contribute to decreased immunity and host defense. It is associated with increased intestinal permeability to endotoxins that is normalized after 14 d of abstinence. Whether and how blood monocyte subsets are impaired in patients with an AUD and what their evolution is after alcohol withdrawal are the paper's objectives. With the use of flow cytometry, blood monocyte subsets were quantified in AUDs before (n = 40) and 2 wk after (n = 33) alcohol withdrawal and compared with HC donors (n = 20). Expression of TLR2 and TLR4 on monocyte subsets was also quantified. Cytokine response of monocytes was monitored following PGN and LPS stimulation. The CD14
+ CD16- subset was decreased, whereas the CD14dim CD16+ subset was expanded (P < 0.001) in AUD compared with HC. The frequencies of TLR2- and TLR4-expressing monocytes were reduced in AUD compared with HC. Although the basal production of IL-1, IL-6, and TNF by monocytes in AUD was compared with HC, the PGN- and LPS-mediated IL-6 and TNF production was increased in AUD. Frequencies of IL-6-expressing monocytes were higher in AUD than HC. Alcohol withdrawal partially restored the distribution of monocyte subsets and the frequency of IL-6-producing monocytes and increased the frequency of TNF-producing cells in response to LPS and PGN stimulation to levels compared with those in HC. Our findings indicate that chronic alcohol use alters the distribution as well as the phenotypic and functional characteristics of blood monocyte subsets, which are partially restored following 2 wk of alcohol withdrawal., (© Society for Leukocyte Biology.)- Published
- 2016
- Full Text
- View/download PDF
140. Deregulation and therapeutic potential of microRNAs in arthritic diseases.
- Author
-
Vicente R, Noël D, Pers YM, Apparailly F, and Jorgensen C
- Published
- 2016
- Full Text
- View/download PDF
141. Inhibition of Inflammation and Bone Erosion by RNA Interference-Mediated Silencing of Heterogeneous Nuclear RNP A2/B1 in Two Experimental Models of Rheumatoid Arthritis.
- Author
-
Herman S, Fischer A, Presumey J, Hoffmann M, Koenders MI, Escriou V, Apparailly F, and Steiner G
- Subjects
- Animals, Arthritis, Rheumatoid immunology, Autoantibodies immunology, Disease Models, Animal, Heterogeneous-Nuclear Ribonucleoprotein Group A-B immunology, Inflammation genetics, Inflammation immunology, Macrophage Activation immunology, Mice, Monocytes immunology, T-Lymphocytes immunology, Arthritis, Experimental genetics, Arthritis, Rheumatoid genetics, Cytokines immunology, Gene Silencing, Heterogeneous-Nuclear Ribonucleoprotein Group A-B genetics, Macrophages immunology, RNA Interference
- Abstract
Objective: The nuclear protein heterogeneous nuclear RNP A2/B1 (hnRNP A2/B1) is involved in posttranscriptional regulation of gene expression. It is constitutively expressed in lymphoid organs and highly up-regulated in the synovial tissue of patients with rheumatoid arthritis (RA), who may also generate autoantibodies to this protein. This study was undertaken to investigate the potential involvement of hnRNP A2/B1 in the pathogenesis of autoimmune arthritis, by silencing hnRNP A2/B1 expression in 2 animal models of RA., Methods: Collagen-induced arthritis (CIA) and the K/BxN serum-transfer model were used as animal models of RA. Efficient silencing of hnRNP A2/B1 was achieved using a liposome-based carrier system for delivery of small interfering RNAs. Expression of hnRNP A2/B1 was analyzed by flow cytometry, reverse transcription-quantitative polymerase chain reaction, Western blotting, and immunohistochemistry. The number of osteoclasts was determined by tartrate-resistant acid phosphatase staining. Cytokine levels and anticollagen antibody levels were measured by enzyme-linked immunosorbent assay., Results: Efficient silencing of hnRNP A2/B1 was achieved in all lymphoid organs. In both experimental models, the incidence and severity of arthritis were largely reduced and bone erosion was not detectable as compared to the control groups. Down-modulation of hnRNP A2/B1 significantly interfered with the production of proinflammatory cytokines from monocyte/macrophages, but not from T cells. Consistent with these findings, production of T cell cytokines was not impaired when cells were restimulated in vitro with type II collagen. Furthermore, levels of anticollagen antibodies were not affected by hnRNP A2/B1 silencing., Conclusion: Our findings suggest that hnRNP A2/B1 has an important role in regulation of the innate immune system, especially at the level of monocyte/macrophage activation. Therefore, down-modulation of hnRNP A2/B1 seems to affect primarily the effector phase of autoimmune arthritis., (© 2015, American College of Rheumatology.)
- Published
- 2015
- Full Text
- View/download PDF
142. MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers.
- Author
-
Duroux-Richard I, Cuenca J, Ponsolles C, Piñeiro AB, Gonzalez F, Roubert C, Areny R, Chea R, Pefaur J, Pers YM, Figueroa FE, Jorgensen C, Khoury M, and Apparailly F
- Subjects
- Adult, Case-Control Studies, Chile, Cluster Analysis, France, Humans, Lupus Erythematosus, Systemic diagnosis, Lupus Nephritis diagnosis, Lupus Nephritis genetics, MicroRNAs metabolism, B-Lymphocyte Subsets metabolism, Biomarkers metabolism, Gene Expression Profiling, Lupus Erythematosus, Systemic genetics, Lupus Erythematosus, Systemic immunology, MicroRNAs genetics
- Abstract
MicroRNAs control the differentiation and function of B cells, which are considered key elements in the pathogenesis of systemic lupus erythematosus (SLE). However, a common micro(mi)RNA signature has not emerged since published data includes patients of variable ethnic background, type of disease, and organ involvement, as well as heterogeneous cell populations. Here, we aimed at identifying a miRNA signature of purified B cells from renal and non-renal severe SLE patients of Latin American background, a population known to express severe disease. Genome-wide miRNA expression analyses were performed on naive and memory B cells and revealed two categories of miRNA signatures. The first signature represents B cell subset-specific miRNAs deregulated in SLE: 11 and six miRNAs discriminating naive and memory B cells of SLE patients from healthy controls (HC), respectively. Whether the miRNA was up or down-regulated in memory B cells as compared with naive B cells in HC, this difference was abolished in SLE patients, and vice versa. The second signature identifies six miRNAs associated with specific pathologic features affecting renal outcome, providing a further understanding for SLE pathogenesis. Overall, the present work provided promising biomarkers in molecular diagnostics for disease severity as well as potential new targets for therapeutic intervention in SLE.
- Published
- 2015
- Full Text
- View/download PDF
143. Transcriptomic network support distinct roles of classical and non-classical monocytes in human.
- Author
-
Anbazhagan K, Duroux-Richard I, Jorgensen C, and Apparailly F
- Subjects
- Cell Movement, Gene Expression Profiling, Humans, Immunity, Innate, Monocytes classification, Atherosclerosis immunology, Bacterial Infections immunology, Cytoskeleton metabolism, Inflammation immunology, Monocytes physiology
- Abstract
Classical and non-classical monocytes are two well-defined subsets of monocytes displaying distinct roles. They differentially express numerous genes relevant to their primary role. Using five independent transcriptomic microarray datasets, we ruled out several inconsistent genes and identified common genes consistently overexpressed either in classical or non-classical monocytes. One hundred and eight genes were significantly increased in classical monocytes and are involved in bacterial defense, inflammation and atherosclerosis. Whereas the 74 genes overexpressed in non-classical monocytes are involved in cytoskeletal dynamics and invasive properties for enhanced motility and infiltration. These signatures unravel the biological functions of monocyte subsets. HIGHLIGHTS We compared five transcriptomic GEO datasets of human monocyte subsets. 108 genes in classical and 74 genes in non-classical monocytes are upregulated. Upregulated genes in classical monocytes support anti-bacterial and inflammatory responses. Upregulated genes in non-classical monocytes support patrolling and infiltration functions.
- Published
- 2014
- Full Text
- View/download PDF
144. Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis.
- Author
-
Duroux-Richard I, Pers YM, Fabre S, Ammari M, Baeten D, Cartron G, Touitou I, Jorgensen C, and Apparailly F
- Subjects
- Aged, Biomarkers blood, Chronic Disease, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Predictive Value of Tests, Rituximab, Treatment Outcome, Antibodies, Monoclonal, Murine-Derived therapeutic use, Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid genetics, Inflammation metabolism, MicroRNAs blood
- Abstract
Although biologic therapies have changed the course of rheumatoid arthritis (RA), today's major challenge remains to identify biomarkers to target treatments to selected patient groups. Circulating micro(mi)RNAs represent a novel class of molecular biomarkers whose expression is altered in RA. Our study aimed at quantifying miR-125b in blood and serum samples from RA patients, comparing healthy controls and patients with other forms of rheumatic diseases and arthritis, and evaluating its predictive value as biomarker for response to rituximab. Detectable levels of miR-125b were measured in total blood and serum samples and were significantly elevated in RA patients compared to osteoarthritic and healthy donors. The increase was however also found in patients with other forms of chronic inflammatory arthritis. Importantly, high serum levels of miR-125b at disease flare were associated with good clinical response to treatment with rituximab three months later (P = 0.002). This predictive value was not limited to RA as it was also found in patients with B lymphomas. Our results identify circulating miR-125b as a novel miRNA over expressed in RA and suggest that serum level of miR-125b is potential predictive biomarker of response to rituximab treatment.
- Published
- 2014
- Full Text
- View/download PDF
145. High efficiency cell-specific targeting of cytokine activity.
- Author
-
Garcin G, Paul F, Staufenbiel M, Bordat Y, Van der Heyden J, Wilmes S, Cartron G, Apparailly F, De Koker S, Piehler J, Tavernier J, and Uzé G
- Subjects
- Animals, Humans, Interferon Type I metabolism, Interferon-alpha metabolism, Interleukin-15 metabolism, Interleukin-2 metabolism, Mice, Protein Binding, Receptor, Interferon alpha-beta metabolism, Receptors, Leptin, Receptors, Tumor Necrosis Factor, Type I metabolism, Cytokines metabolism, Drug Delivery Systems, Leptin metabolism, Receptors, Cytokine metabolism, Single-Domain Antibodies metabolism
- Abstract
Systemic toxicity currently prevents exploiting the huge potential of many cytokines for medical applications. Here we present a novel strategy to engineer immunocytokines with very high targeting efficacies. The method lies in the use of mutants of toxic cytokines that markedly reduce their receptor-binding affinities, and that are thus rendered essentially inactive. Upon fusion to nanobodies specifically binding to marker proteins, activity of these cytokines is selectively restored for cell populations expressing this marker. This 'activity-by-targeting' concept was validated for type I interferons and leptin. In the case of interferon, activity can be directed to target cells in vitro and to selected cell populations in mice, with up to 1,000-fold increased specific activity. This targeting strategy holds promise to revitalize the clinical potential of many cytokines.
- Published
- 2014
- Full Text
- View/download PDF
146. Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis.
- Author
-
Présumey J, Courties G, Louis-Plence P, Escriou V, Scherman D, Pers YM, Yssel H, Pène J, Kyburz D, Gay S, Jorgensen C, and Apparailly F
- Subjects
- Animals, Arthritis, Experimental prevention & control, CD4-Positive T-Lymphocytes immunology, Coculture Techniques, Cytokines biosynthesis, Cytokines genetics, Gene Silencing, Humans, Immunomodulation immunology, Interleukin-6 biosynthesis, Lipopolysaccharide Receptors analysis, Mice, Mice, Inbred DBA, Nicotinamide Phosphoribosyltransferase genetics, RNA, Small Interfering genetics, Th17 Cells immunology, Arthritis, Experimental immunology, Cytokines immunology, Monocytes immunology, Nicotinamide Phosphoribosyltransferase immunology
- Abstract
Objectives: Nicotinamide phosphoribosyltransferase (NAMPT)/pre-B-cell colony-enhancing factor/visfatin exerts multiple functions and has been implicated in the pathogenesis of rheumatoid arthritis. To gain insight into its role in arthritis and given that NAMPT is identified as a novel mediator of innate immunity, we addressed the function of monocyte-derived NAMPT in experimental arthritis by selective gene knockdown in inflammatory monocytes., Methods: siRNA uptake and NAMPT expression were determined in Ly6Chigh and Ly6Clow monocyte subsets following intravenous injection of siRNA against NAMPT (siNAMPT) or non-targeting siRNA (siCT) formulated with the DMAPAP cationic liposome into mice. Mice with established collagen-induced arthritis (CIA) were treated weekly after disease onset with siNAMPT or siCT and clinical features were assessed. T-helper cell frequencies, cytokine production and percentage of IL-6-producing Ly6Chigh monocytes were analysed. Using a co-culture system consisting of purified CD14 monocytes and autologous CD4 T cells, NAMPT and cytokine production, and the percentage of IL-17-producing CD4 T cells, were determined following transfection of CD14 monocytes with siCT or siNAMPT., Results: On intravenous injection, siRNA was preferentially engulfed by Ly6Chigh monocytes, and siRNA-mediated silencing of NAMPT expression in Ly6Chigh monocytes inhibited CIA progression. This effect was associated with reduced IL-6 production by Ly6Chigh monocytes, reduced proportion of Th17 cells and autoantibody titers, and decreased activation and infiltration of monocytes/macrophages and neutrophils in arthritic joints. Moreover, NAMPT-RNAi-silenced CD14 monocytes were found to reduce the percentage of IL-17-producing CD4 T cells in vitro., Conclusions: Our results show that the expression of NAMPT in Ly6Chigh monocytes promotes many downstream effects involved in inflammatory arthritis and demonstrate the utility of targeting disease-causing genes, such as NAMPT, in Ly6Chigh monocytes for therapeutic intervention in arthritis.
- Published
- 2013
- Full Text
- View/download PDF
147. Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.
- Author
-
Davignon JL, Hayder M, Baron M, Boyer JF, Constantin A, Apparailly F, Poupot R, and Cantagrel A
- Subjects
- Animals, Arthritis, Rheumatoid immunology, Dendrimers, Humans, Tumor Necrosis Factor-alpha immunology, Arthritis, Rheumatoid therapy, Gene Silencing drug effects, Group IV Phospholipases A2 genetics, Macrophages enzymology, Molecular Targeted Therapy methods, Monocytes enzymology, RNA, Small Interfering therapeutic use
- Abstract
Biotherapies have revolutionized the treatment of RA. However, much work is needed to understand all the mechanisms of these biotherapies, and alternatives are needed to circumvent adverse effects and the high cost of these long-lasting treatments. In this article we outline some of the approaches we have used to target monocytes/macrophages as major components of inflammation and bone homeostasis. We also discuss how anti-TNF-α antibodies target monocytes/macrophages in the complex mechanisms contributing to inhibition of inflammation.
- Published
- 2013
- Full Text
- View/download PDF
148. Impact of microRNAs on the understanding and treatment of rheumatoid arthritis.
- Author
-
Ammari M, Jorgensen C, and Apparailly F
- Subjects
- Animals, Arthritis, Rheumatoid etiology, Arthritis, Rheumatoid therapy, Bone Remodeling genetics, Epigenesis, Genetic, Gene Expression Regulation, Humans, Mice, MicroRNAs metabolism, Models, Biological, Signal Transduction, Tissue Distribution, Arthritis, Rheumatoid genetics, MicroRNAs genetics
- Abstract
Purpose of Review: It is becoming more and more obvious that epigenetic processes influence the development of rheumatic diseases as strongly as the genetic background. Research on the role of microRNAs (miRNAs) in rheumatic diseases, and especially in rheumatoid arthritis (RA), has been very active for the past 5 years. Most studies have reported the aberrant expression of miRNAs in the circulation or joint tissues, and the pathogenic role of a few of them has been investigated in the experimental models., Recent Findings: As inflammation and joint damage are the main hallmarks of RA, we focused on the three miRNAs, miR-146a, miR-155 and miR-223, whose functions have been studied in both the processes and the pathogenic role investigated in the experimental models., Summary: Focusing on the role of miR-146a, miR-155 and miR-223 in RA pathogenesis emphasizes the intertwined relationships between bone homeostasis and immunity, and the prominent role of monocytes in RA. Studying the miRNAs in RA will shed light on the pathological processes and help in identifying novel drug candidates and biomarkers.
- Published
- 2013
- Full Text
- View/download PDF
149. siRNA-based therapeutic approaches for rheumatic diseases.
- Author
-
Apparailly F and Jorgensen C
- Subjects
- Animals, Arthritis, Rheumatoid genetics, Disease Models, Animal, Drug Delivery Systems, Humans, Mice, Osteoarthritis genetics, RNA Interference, RNA, Small Interfering administration & dosage, Rats, Arthritis, Rheumatoid drug therapy, Gene Silencing, Osteoarthritis drug therapy, RNA, Small Interfering therapeutic use
- Abstract
RNA interference (RNAi) is one of the most exciting and important discoveries of the past few decades. Small interfering RNAs (siRNAs) can silence gene activity and be used to interfere with pathophysiological processes. Substantial research has focused on introducing 'drug-like' properties-stability, selectivity and potency-to RNAi molecules, and clinical trials have been initiated. Despite initial success, the current challenge that remains is to develop optimized vehicles that avoid off-target effects whilst efficiently delivering the therapeutic siRNA to specific cell types. As for many other diseases, siRNA-based therapy is emerging as a promising approach for the treatment of rheumatic disorders. Although the pathogenesis of rheumatic diseases is complex, identification of candidate genes able to influence either inflammation or structural damage has been successful. Here, we will discuss advances in the field and potential applications of siRNA therapeutics in clinical trials for rheumatic conditions.
- Published
- 2013
- Full Text
- View/download PDF
150. PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints.
- Author
-
Présumey J, Salzano G, Courties G, Shires M, Ponchel F, Jorgensen C, Apparailly F, and De Rosa G
- Subjects
- Animals, Arthritis, Experimental therapy, Arthritis, Rheumatoid therapy, Cell Line, Drug Design, Lactic Acid chemistry, Mice, Mice, Inbred DBA, Microspheres, Particle Size, Polyglycolic Acid chemistry, Polylactic Acid-Polyglycolic Acid Copolymer, RNA Interference, Time Factors, Arthritis, Experimental pathology, Arthritis, Rheumatoid pathology, RNA, Small Interfering administration & dosage, Tumor Necrosis Factor-alpha genetics
- Abstract
The aim of this study was to investigate potentialities of poly(dl-lactide-co-glycolide) (PLGA) microspheres for the delivery of small interfering RNAs (siRNAs) against tumor necrosis factor α (TNF-α) to achieve prolonged and efficient inhibition of TNF-α for the treatment of rheumatoid arthritis (RA). PLGA microspheres were prepared by a modified multiple emulsion-solvent evaporation method. The formulations were characterized in terms of morphology, mean diameter and siRNAs distribution, encapsulation efficiency, and in vitro release kinetics. The efficiency of this system was then evaluated both in vitro and in vivo using the murine monocytic cell line J774 and a pre-clinical model of RA, respectively. siRNA-encapsulating PLGA microspheres were characterized by a high encapsulation efficiency and a slow and prolonged anti-TNF-α siRNAs. Our results provide evidence that, upon intra-articular administration, PLGA microspheres slowly releasing siRNAs effectively inhibited the expression of TNF-α in arthritic joints. Our system might represent an alternative strategy for the design of novel anti-rheumatic therapies based on the use of RNA interference in RA., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.